Marketdash
Back to News

Wall Street Analysts Kick Off Coverage With Five Fresh Stock Ratings

MarketDash Editorial Team
1 day ago
Five companies caught the attention of major Wall Street analysts this week, with QXO receiving a notably bullish initiation and price target well above its current trading level. From healthcare to water technology, here's what the pros are saying.

Friday brought a fresh batch of analyst initiations across sectors, with Wall Street's research desks weighing in on everything from healthcare networks to location tracking apps. The most optimistic call went to QXO, but several other companies also landed on analyst radars for the first time.

Needham analyst Matthew Shea started coverage on Astrana Health Inc. (ASTH) with a Buy rating and set a price target of $28. That represents decent upside from Thursday's closing price of $22.46. Astrana operates a network of physician practices and value-based care arrangements, making it a play on the ongoing shift in how healthcare gets delivered and paid for.

The headline grabber was Loop Capital analyst Garik Shmois initiating coverage on QXO Inc. (QXO) with a Buy rating and a $31 price target. QXO closed Thursday at $22.12, so that target implies roughly 40% upside if Shmois is right. The company, which focuses on building distribution businesses, clearly has believers on Wall Street betting on its strategy.

Not every initiation came with fireworks, though. Jefferies analyst Andrew Tsai took a more cautious stance on Moderna Inc. (MRNA), starting coverage with a Hold rating and a $30 price target. Moderna shares finished Thursday at $29.63, essentially right at that target level. The biotech company, still navigating life after its COVID-19 vaccine windfall, faces questions about its pipeline and future revenue streams.

DA Davidson analyst Wyatt Swanson initiated coverage on Life360 (LIF) with a Buy rating and set an ambitious $94 price target. The family location and safety app company closed Thursday at $69.06, making this one of the more aggressive bullish calls in Friday's batch. Life360 has been growing its subscription base and expanding its features beyond simple location tracking.

Rounding out the initiations, Jefferies analyst James Ko began coverage on Watts Water Technologies Inc. (WTS) with a Hold rating and a $300 price target. Watts Water shares closed at $277.92 on Thursday, leaving modest upside if the company hits that mark. The industrial manufacturer makes water quality and flow control products, serving both residential and commercial markets.

These initiation calls give investors a fresh perspective on companies that may have been flying under the radar. Buy ratings on QXO and Life360 suggest analysts see meaningful growth opportunities, while the Hold ratings indicate a more measured outlook where the current price fairly reflects near-term prospects.

Back to News

Wall Street Analysts Kick Off Coverage With Five Fresh Stock Ratings

MarketDash Editorial Team
1 day ago
Five companies caught the attention of major Wall Street analysts this week, with QXO receiving a notably bullish initiation and price target well above its current trading level. From healthcare to water technology, here's what the pros are saying.

Friday brought a fresh batch of analyst initiations across sectors, with Wall Street's research desks weighing in on everything from healthcare networks to location tracking apps. The most optimistic call went to QXO, but several other companies also landed on analyst radars for the first time.

Needham analyst Matthew Shea started coverage on Astrana Health Inc. (ASTH) with a Buy rating and set a price target of $28. That represents decent upside from Thursday's closing price of $22.46. Astrana operates a network of physician practices and value-based care arrangements, making it a play on the ongoing shift in how healthcare gets delivered and paid for.

The headline grabber was Loop Capital analyst Garik Shmois initiating coverage on QXO Inc. (QXO) with a Buy rating and a $31 price target. QXO closed Thursday at $22.12, so that target implies roughly 40% upside if Shmois is right. The company, which focuses on building distribution businesses, clearly has believers on Wall Street betting on its strategy.

Not every initiation came with fireworks, though. Jefferies analyst Andrew Tsai took a more cautious stance on Moderna Inc. (MRNA), starting coverage with a Hold rating and a $30 price target. Moderna shares finished Thursday at $29.63, essentially right at that target level. The biotech company, still navigating life after its COVID-19 vaccine windfall, faces questions about its pipeline and future revenue streams.

DA Davidson analyst Wyatt Swanson initiated coverage on Life360 (LIF) with a Buy rating and set an ambitious $94 price target. The family location and safety app company closed Thursday at $69.06, making this one of the more aggressive bullish calls in Friday's batch. Life360 has been growing its subscription base and expanding its features beyond simple location tracking.

Rounding out the initiations, Jefferies analyst James Ko began coverage on Watts Water Technologies Inc. (WTS) with a Hold rating and a $300 price target. Watts Water shares closed at $277.92 on Thursday, leaving modest upside if the company hits that mark. The industrial manufacturer makes water quality and flow control products, serving both residential and commercial markets.

These initiation calls give investors a fresh perspective on companies that may have been flying under the radar. Buy ratings on QXO and Life360 suggest analysts see meaningful growth opportunities, while the Hold ratings indicate a more measured outlook where the current price fairly reflects near-term prospects.